198 related articles for article (PubMed ID: 36197268)
41. Long noncoding RNA CRNDE functions as a diagnostic and prognostic biomarker in osteosarcoma, as well as promotes its progression via inhibition of miR-335-3p.
Yu Y; Wang L; Li Z; Zheng Y; Shi Z; Wang G
J Biochem Mol Toxicol; 2021 May; 35(5):e22734. PubMed ID: 33522065
[TBL] [Abstract][Full Text] [Related]
42. MiR-455-3p downregulation facilitates cell proliferation and invasion and predicts poor prognosis of osteosarcoma.
Yi X; Wang Y; Xu S
J Orthop Surg Res; 2020 Oct; 15(1):454. PubMed ID: 33008443
[TBL] [Abstract][Full Text] [Related]
43. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
Zhang L; Zhao G; Ji S; Yuan Q; Zhou H
Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139
[TBL] [Abstract][Full Text] [Related]
44. Increased expression of microRNA-26a-5p predicted a poor survival outcome in osteosarcoma patients: An observational study.
Xie XY; Chen XM; Shi L; Liu JW
Medicine (Baltimore); 2021 Mar; 100(12):e24765. PubMed ID: 33761638
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-1274a serves as a prognostic biomarker in patients with osteosarcoma and is involved in tumor progression via targeting ADAM9.
Feng XT; Wang C; Zhang FJ; Wu XQ; Zhang Z
J Biol Regul Homeost Agents; 2021; 35(1):151-160. PubMed ID: 33543608
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-1296-5p suppresses the proliferation, migration, and invasion of human osteosarcoma cells by targeting NOTCH2.
Wang L; Hu K; Chao Y; Wang X
J Cell Biochem; 2020 Feb; 121(2):2038-2046. PubMed ID: 31633240
[TBL] [Abstract][Full Text] [Related]
47. Combined microRNA-340 and ROCK1 mRNA profiling predicts tumor progression and prognosis in pediatric osteosarcoma.
Cai H; Lin L; Cai H; Tang M; Wang Z
Int J Mol Sci; 2014 Jan; 15(1):560-73. PubMed ID: 24398981
[TBL] [Abstract][Full Text] [Related]
48. Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma.
Zeng H; Zhang Z; Dai X; Chen Y; Ye J; Jin Z
Pathol Oncol Res; 2016 Apr; 22(2):253-60. PubMed ID: 26183062
[TBL] [Abstract][Full Text] [Related]
49. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.
Zou P; Ding J; Fu S
Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202
[TBL] [Abstract][Full Text] [Related]
50. Clinical significance of microRNA-34a in esophageal squamous cell carcinoma.
Lin X; Xu XY; Chen QS; Huang C
Genet Mol Res; 2015 Dec; 14(4):17684-91. PubMed ID: 26782413
[TBL] [Abstract][Full Text] [Related]
51. A novel small-molecule antagonist enhances the sensitivity of osteosarcoma to cabozantinib in vitro and in vivo by targeting DNMT-1 correlated with disease severity in human patients.
Wang JH; Zeng Z; Sun J; Chen Y; Gao X
Pharmacol Res; 2021 Nov; 173():105869. PubMed ID: 34481973
[TBL] [Abstract][Full Text] [Related]
52. Circular RNA MTO1 intercorrelates with microRNA-630, both associate with Enneking stage and/or pathological fracture as well as prognosis in osteosarcoma patients.
Shi Z; Wen Y; Zhang S; Cheng X
J Clin Lab Anal; 2021 Nov; 35(11):e23987. PubMed ID: 34545623
[TBL] [Abstract][Full Text] [Related]
53. Low miR-34a and miR-192 are associated with unfavorable prognosis in patients suffering from osteosarcoma.
Wang Y; Jia LS; Yuan W; Wu Z; Wang HB; Xu T; Sun JC; Cheng KF; Shi JG
Am J Transl Res; 2015; 7(1):111-9. PubMed ID: 25755833
[TBL] [Abstract][Full Text] [Related]
54. miR-106a-5p Suppresses the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Targeting HMGA2.
He QY; Wang GC; Zhang H; Tong DK; Ding C; Liu K; Ji F; Zhu X; Yang S
DNA Cell Biol; 2016 Sep; 35(9):506-20. PubMed ID: 27383537
[TBL] [Abstract][Full Text] [Related]
55. Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth.
Zhao Y; Tu MJ; Yu YF; Wang WP; Chen QX; Qiu JX; Yu AX; Yu AM
Biochem Pharmacol; 2015 Dec; 98(4):602-13. PubMed ID: 26518752
[TBL] [Abstract][Full Text] [Related]
56. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.
Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z
Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921
[TBL] [Abstract][Full Text] [Related]
57. Prognostic value of low microRNA-34a expression in human gastrointestinal cancer: a systematic review and meta-analysis.
Chen YL; Liu XL; Li L
BMC Cancer; 2021 Jan; 21(1):63. PubMed ID: 33446130
[TBL] [Abstract][Full Text] [Related]
58. miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1.
Xu M; Jin H; Xu CX; Sun B; Song ZG; Bi WZ; Wang Y
Mol Ther; 2015 Jan; 23(1):89-98. PubMed ID: 25292190
[TBL] [Abstract][Full Text] [Related]
59. MiR-451 inhibits cell growth and invasion by targeting CXCL16 and is associated with prognosis of osteosarcoma patients.
Zhang F; Huang W; Sheng M; Liu T
Tumour Biol; 2015 Mar; 36(3):2041-8. PubMed ID: 25391425
[TBL] [Abstract][Full Text] [Related]
60. Expression of microRNA-150 and its Target Gene IGF2BP1 in Human Osteosarcoma and their Clinical Implications.
Wang L; Aireti A; Aihaiti A; Li K
Pathol Oncol Res; 2019 Apr; 25(2):527-533. PubMed ID: 30220021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
